ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Selective Vascular Decellularization and Endothelial Cells Replacement as a Strategy to Reduce Reperfusion Injury in Bioartificial Organs

G. Haeublein1, G. Lombardi1, F. Caro1, R. Carla1, D. Guerrieri1, C. Incardona2, D. Casadei3, E. Chuluyan1

1CEFYBO, Buenos Aires, Argentina, 2GADOR S.A., Buenos Aires, Argentina, 3Fundación Argentina de Trasplante, Tercer Milenio, Buenos Aires, Argentina

Meeting: 2022 American Transplant Congress

Abstract number: 640

Keywords: Bioengineering, Endothelial activation, Endothelial cells, Kidney

Topic: Basic Science » Basic Science » 06 - Tissue Engineering and Regenerative Medicine

Session Information

Session Name: Tissue Engineering and Regenerative Medicine

Session Type: Poster Abstract

Date: Saturday, June 4, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-7:00pm

Location: Hynes Halls C & D

*Purpose: The number of kidney transplants performed each year cannot meet the increasing demand of these organs. Several strategies aim to increasing the offer of immune compatible organs, such as xenotransplantation of genetically modified pig organs and the generation of bioartificial organs. Herein we described a new technique that allows us to generate a rat bioartificial kidney whose endothelial cells have been replaced with human endothelial cells in order to reduce the immunogenicity of allografts.

*Methods: Two different protocols were used in order to maintain parenchyma epithelial cells and remove selectively rat endothelial cells. In the first one, 2ml of a solution of 0.01% of SDS was perfused via renal artery at 4°C. For the second protocol, the rat kidney was perfused with increasing osmolarity solutions of saccharose and EDTA at room temperature for 15 minutes. The effectiveness of partial decellularization was calculated by comparing those endothelial cell decellularized kidneys with a kidney that has been decellularized with collagenase (positive control). Albumin conjugated to Evans blue dye was perfused through the artery in order to evaluate vascular permeability.

*Results: Both endothelial cell decellularization protocols achieved a similar vascular permeability while the second group maintained a better epithelial cell viability assessed with TUNEL assay (40 % vs 65 %). Afterwards, partially decellularized kidneys were recellularized (2 hours at 37°C) with 7×106 human endothelial cells transfected with GFP protein. Histological analysis showed HMEC-GFP attached in almost all the vascular bed. Finally, recellularized kidneys were transplanted in an anesthetized rat. After surgery, complete organ perfusion was achieved and also urine production for at least 30 min pos-transplant.

*Conclusions: These results suggest that endothelial decellularization and recellularization with human cells can be feasible methods in order to generate a more immune compatible bioartificial organs.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Haeublein G, Lombardi G, Caro F, Carla R, Guerrieri D, Incardona C, Casadei D, Chuluyan E. Selective Vascular Decellularization and Endothelial Cells Replacement as a Strategy to Reduce Reperfusion Injury in Bioartificial Organs [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/selective-vascular-decellularization-and-endothelial-cells-replacement-as-a-strategy-to-reduce-reperfusion-injury-in-bioartificial-organs/. Accessed May 8, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences